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Abstract 
 
Acute respiratory illnesses (ARI) are common in children and symptoms range from 
days to weeks.   
Aim: The aim of the study was to determine if children with asthma have more severe 
ARI episodes compared to children with protracted bronchitis and controls.   
 
Methods: Parents prospectively scored their child’s next acute respiratory illness using 
the CARIFS and validated cough diary (on days 1 to 7, 10 & 14 of illness).  Children 
were age and season matched. 
 
Results: On day 10 and 14 of illness children with protracted bronchitis had 
significantly higher median CARIFS when compared with children with asthma and 
healthy controls.  On day-14, the median CARIFS were: asthma = 4.1 (IQR 4.0), 
protracted bronchitis = 19.6 (IQR 25.8) and controls = 4.1 (IQR 5.25).  The median 
cough score was significantly different between groups on day 1, 7, 10 and 14 
(p<0.001).  A significantly higher proportion of children with protracted bronchitis 
(63%) were still coughing at day 14 in comparison to children with asthma (24%) and 
healthy controls (26%).   
 
Conclusion: Children with protracted bronchitis had the most severe ARI symptoms and 
higher percentage of respiratory morbidity at day 14 in comparison to children with 
asthma and healthy controls.
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Introduction   
Acute respiratory infections (ARI) are common in children, varying from 4 episodes per 
year in the first 2 years of life to 2-3 episodes per year when aged 2 to 5 years.(1)  The 
morbidity of acute respiratory infections (ARI) in children include cough and non- 
specific symptoms such as irritability.(2)  Among individuals, these symptoms vary in 
severity and length of illness.(1) Cough related to ARI generally resolves between 1 to 3 
weeks in most children.(3, 4)  Although health practitioners often view ARIs as a 
benign self-limiting illness, parental concerns regarding the length and severity of their 
children’s symptoms and illness often lead to presentation to their family doctor.(1, 5)  
Furthermore to ameliorate the symptoms of ARIs, “over-the-counter” cold and cough 
medications are often used.(6)  Indeed “over-the-counter” cough and cold medications 
costs the community billions of dollars each year despite the lack of evidence on their 
efficacy.(7) 
  
In children with asthma, ARIs often lead to acute exacerbations of asthma.(8)  Acute 
asthma exacerbations in children are a common presentation to emergency departments 
and are a substantial economic burden on healthcare system.(9)  Additionally, it places a 
burden on the children, their parents and families and is associated with a decrease in 
their quality of life.(10, 11)  Yet, there are no studies (PubMed search - May 2007) that 
have examined the severity or length of ARI symptoms in children with acute asthma.  
  
 
Children with some conditions such as tracheomalacia and protracted bronchitis have 
prolonged coughing(12) illnesses.  Cough is the most common symptom presenting to 
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doctors in USA(13) and Australia, and one of the most common symptom of an acute 
respiratory infection. Protracted bronchitis is a recently described entity(14) that has 
probably been recognized but not well described until recently.(15)  It is clinically 
defined as (a) the presence of isolated chronic moist cough, (b) resolution of cough with 
appropriate antibiotics, (c) absence of pointers suggestive of alternative specific cough 
(12) and (d) positive bronchoalveolar lavage culture (growth of >104 colony forming 
units/ml). (14)  One likely contributing factor to PB is innate immunity dysfunction.(16)  
Whether children with PB have more severe ARI symptoms are however unknown.  
 
Measurement of the severity of ARI symptoms are however limited as there are few 
validated instruments.  One validated instrument is the Canadian Acute Respiratory 
Illness Scale (CARIFS)(17) which  has been utilized in several settings.(18)  Another 
validated instrument is that for the symptom of cough (19), a common symptom of 
ARIs.  
  
The aim of our study was to determine if children with asthma or protracted bronchitis 
have more severe ARI symptoms at presentation and at days 7, 10 and 14 using 
validated scales (CARIFS and cough score)(17, 19) compared to controls.  We also 
examined (using a validated cough score(19)) if children with asthma or protracted 
bronchitis were more likely to have a persistent cough on day 14 than controls.  We 
hypothesised that children with asthma have more severe and/or prolonged ARI 
symptoms than the other two groups.  
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Methods & Materials  
Subjects 
Three groups of children were recruited: children with asthma (n=72), children with 
protracted bronchitis (n=19) and healthy controls (n=23).  The two first groups were 
primarily from other studies.  Children with asthma were recruited from an emergency 
department during an acute exacerbation of the child’s asthma.  Asthma was defined as 
recurrent (>2) episodes of wheeze and/or dyspnoea with a clinical response (decreased 
respiratory rate and work of breathing) to beta2 agonist.  An asthma exacerbation was 
defined as acute deterioration of asthma control requiring treatment with more than a 
single dose (>600ug via metered dose inhaler and spacer or >2.5mg nebulised) of 
salbutamol in an hour.  The children with asthma were prescribed either 3 or 5 days of 
oral prednisone and no difference was found between the groups, as also described by 
others.(20)  Parents of children with protracted bronchitis (as defined above) were from 
another study.(14) The children from this study underwent sweat tests and other 
pathological investigations to exclude presence of other respiratory illnesses such as 
cystic fibrosis.(14) The parents were approached during an outpatients visit. The parents 
were asked to document their next ARI episode.  Each child with protracted bronchitis 
had undergone a bronchoscopy to determine if any airway lesion was present. Children 
were excluded if tracheomalacia or bronchomalacia was present.(21)  Controls were 
recruited from a convenient sample of family and friends; they had no history of 
smoking, or presence of asthma.  The parents were asked to document the next ARI 
episode once the child had 24 hours of runny nose, cough, sore throat and/or fever. 
Exclusion criteria were children with neuro-developmental dysfunction, 
cardiorespiratory illnesses (eg cystic fibrosis or tracheomalacia) or children with any 
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type of immunodeficiency.  Written informed consent was obtained and the studies 
were approved by our institution’s ethics committee. 
 
Protocol 
All parents completed two types of daily diary cards (CARIFS(17) and cough(19)) for 
the first 7 days and on days 10 and 14 of illness at enrolment (for asthma group) or 
during the next episode when their child was unwell with an ARI (for the protracted 
bronchitis group and controls).  The parents of children with protracted bronchitis and 
controls were asked to start filling out the diary cards after their child had been sick for 
at least 24 hours with symptoms of cough, runny nose, sore throat and/or fever.  The 
protracted bronchitis group and controls were age and season matched for the asthma 
group (Winter period = April to September; Summer period= October to March).  
Reminders were sent to the later two groups on a monthly basis.  
 
Canadian Acute Respiratory Illness and Flu Scale (CARIFS) 
CARIFS (Table 1) was “developed as a parentally assessed disease severity measure 
appropriate for acute respiratory infection, including influenza, in children”.(18)  The 
scale consists of 18 items that included measurements of symptoms (eg. cough), 
function (eg. play) and parental impact (eg. clingliness).(17)  Each item has a 4-point 
ordinal score; “Major Problem”=3, “Moderate Problem”=2, “Minor Problem”=1 and 
“No Problem”=0. In addition, items could also be scored as “Don’t know or Not 
Applicable”.  Each set of parents completed diary cards for the morning (AM) and 
evening (PM).  The final daily accumulated score is derived from addition of all the 
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scores, divided by the total number of questions answered multiplied by 36 (the total 
number of questions that could have been answered for both AM and PM). 
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Cough Diary 
The validated cough diary utilised was one that included a measure of impact.(19)  The 
child’s cough was scored as follows:  0 = no cough; 1 = cough for one or two short 
periods only; 2 = cough for more than two short periods; 3 = frequent coughing but does 
not interfere with school or other activities; 4 = frequent coughing which interferes with 
school or other activities; and 5 = cannot perform most usual activities due to severe 
coughing. 
 
Statistical analysis 
The children were categorized into 3 groups: asthma, protracted bronchitis or healthy 
controls. Non-parametric analysis was used as the data were not normally distributed.  
Kruskal Wallis or Mann Whitney test was used for three and two group comparisons 
respectively.  Chi square was used to compare categorical variables.  Spearman 
correlation coefficient was used to measure the relationship between variances.  SPSS 
version 13 was used for all statistical calculations.  A 2-tailed p value of ≤0.05 was 
considered significant.  
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Results  
The demographics (age, gender, season of ARI) of the children enrolled were matched 
(Table-2).  The median age (IQR) of the combined group was 3.8 (3.8), with 64 boys 
and 50 girls.  The median age (IQR) of the 3 groups of children were; asthma = 3.8 
years (3.8), protracted bronchitis = 3.3 (3.9) and controls =3.9 (3.4), p= 0.49.  Of the 72 
children with asthma, 39 were male and 33 were female.  In the group of 19 children 
with protracted bronchitis, 12 were male and 7 were female.  The healthy control group 
had 14 males and 9 females.  There was no significant difference in gender among the 
groups (p =0.87).  There was also no significant difference between the seasons when 
dividing the year into 2 seasons; Winter period (April to September) and Summer 
period (October to March).  Sixty-five of the illnesses began in the season April – 
September and 49 between October and March.  In the winter period, 43 ARIs were 
from children with asthma, 11 from protracted bronchitis group and 10 from healthy 
controls.  In the summer season, the numbers were 29, 8 and 13 ARIs respectively.  
There was no significant difference among the 3 groups (p = 0.391) in relation to the 
seasons. 
 
On day-1 of the ARI there was no difference between the median accumulated CARIFS 
score, p = 0.168.  The median CARIFS score were: group with asthma = 34 (IQR 34.8), 
group with protracted bronchitis = 36 (IQR 36.6) and controls = 24.4 (28.0) (figure 1).  
However, children with protracted bronchitis had a significantly higher median CARIFS 
score than children with asthma and controls on days 10 and 14 of illness, p <0.001 and 
p<0.001 respectively.  On day-14, the median CARIFS score were: asthma = 4.1 (IQR 
4.0), protracted bronchitis = 19.6 (IQR 25.8) and controls = 4.1 (IQR 5.25) (figure 1).  
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Cough scores 
On day 1 median cough scores were significantly different between groups (p<0.001); 
median (IQR) in the group with asthma was 3.0 (1.45), protracted bronchitis = 3.0 (2.0), 
and healthy control = 1.0 (1.0).  The median scores were also significantly different 
between groups on days 7, 10 and 14.  By day 14 the median cough scores (IQR) were: 
asthma group = 0 (1.0), protracted bronchitis group = 2.0 (2.0), and healthy control 
group = 1.0 (1.25). (figure 2) 
 
When those with asthma were compared to those with PB, the groups were similar on 
day 1 (p=0.83) but the asthma group had a significantly lower score on days 7, 10 and 
14 of ARI (p for all <0.001).  Similarly, healthy controls did not significantly differ 
from children with PB on day 1 (p=0.08) but differed significantly on day 7, 10 and 14 
p=0.03, p=0.02 and p=0.02 respectively.  The scores in children with asthma and the 
healthy controls were more similar on day-7 (p=0.56), day-10 (p=0.21) and day-14 
(p=0.5) but significantly differed on Day-1 (p<0.001) (Table 3).   
 
When evaluated by proportions, there was a significant difference between the groups 
with children with PB had the highest proportion still coughing on days 7, 10 and 14 
(Table 4). The proportion of children with asthma who were coughing were 
significantly higher than controls on day 1 (p <0.001 but similar to controls on days 7, 
10 and 14 (p = 0.56, 0.21 and 0.05 respectively).  Cough scores significantly related to 
CARIFS scores on all days (day-1, rs=0.574, p<0.001; day-7, rs=0.477, p=<0.001; day-
10, rs=0.639, p<0.001; and day-14, rs=0.499, p<0.001. 
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Discussion  
This is the first study to compare the severity of acute respiratory illnesses as measured 
by CARIFS and cough scores in children with asthma, protracted bronchitis and healthy 
children. We have demonstrated that children with asthma had more severe scores than 
controls in the early phase of the asthma exacerbation but not in the later phase (D10 
onwards).  In contrast, children with protracted bronchitis had the most severe scores 
and 63% were still coughing by day 14.  
 
Despite the commonality of ARIs, there is relatively little data on the impact and effect 
of ARIs in children.  In the validation phase of CARIFS, Jacob et al(17) reported that by 
day-14, 80% of their study subjects had a CARIFS score of less than 3.  Butler et al(22) 
stated that <7% of their 240 subjects were still unwell at day-14 as scored using 
CARIFS.  Both these studies were of children who were presenting to their general 
practitioner with ARI, ie they were children from the community and thus likely to be 
otherwise well children.  Our data on healthy controls were similar with their data as we 
found that the controls had day-14 CARIFS scores of 4.1.  However we could not find 
any study on (Pubmed search 29 May 2007) using CARIFS on children with asthma.  
Thus this study is unique as we examined if children with asthma have more severe ARI 
episodes at presentation and at days 7, 10 and 14 using validated scales (CARIFS and 
cough score).  Authors have described that children with asthma are likely to have more 
ARIs(9) and thus it is biologically possible that children with asthma also have more 
severe ARIs.  However we found that on subjective scoring using CARIFS, parents of 
children with asthma reported similar profiles to controls on days 10 onwards.  Using 
the CARIFS, children with asthma had higher score only on day 7 but by day 10, had 
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similar score to controls.  The cough diary scores of children with asthma were higher 
than controls on day-1 but not on other days.  The differences found between the 2 
scales is not surprising as the scales utilized were designed to measure different things.  
Furthermore it is known that the severity of cough has a poor relationship to severity of 
asthma.(23, 24) 
 
In our study, children with protracted bronchitis had the highest CARIFS score on days 
7, 10 and 14 and this was significantly higher than children with asthma or healthy 
controls. Protracted bronchitis is a condition characterized by isolated chronic (>4 
weeks) wet cough that responds to antibiotics.(14)  One possible reason why the 
severity of ARI is higher in this group is the presence of dysfunction of the innate 
immunity such as reduced expression of Toll-like receptors 2 and 4 in the airway 
cells.(16)  
 
Another possible reason is that the subjective reporting as our results have to be 
interpreted with the knowledge that parental reporting of childhood respiratory 
symptoms can be biased and parental perceptions are likely to play an important 
role.(25)  However, as young children are unable to verbally express themselves 
adequately, it is standard practice for parents to be proxy assessors of their young child. 
Moreover the burden of illness is real and Juniper and colleagues have shown that 
physicians are poor assessors of the burden of illness.(26) Nevertheless biased reporting 
as the reason why children of different groups have significant different scores are 
unlikely as we have previously shown the number of coughs objectively recorded on a 
cough-meter per subjective score unit in diaries completed by parents of children with 
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chronic cough was significantly higher than that of diaries completed parents of 
otherwise well children.(27)  This suggests that parents of children with chronic cough 
are unlikely to exaggerate the severity of their child’s cough.  Also Wyke and 
colleagues had shown that the higher severity of cough in socio-economically deprived 
children was real and not because of parental exaggeration.(28) 
 
Our study was also limited by the small sample size in the controls.  A larger sample 
size in the protracted bronchitis group and healthy controls would have been beneficial.  
In addition to the limited sample size, this study looked at one episode of illness only 
and limited to a 14 day period.  A further limitation is that we do not have polymerase 
chain reaction (PCR) data for viral detection on these children.  The children with 
asthma were recruited during an exacerbation and received oral corticosteroids which 
could influence the morbidity of this group. Family history or personal history of atopy 
was not reported in any of our groups. Children with atopy have more prolonged 
respiratory symptoms. Given these limitations, our study’s findings should be 
confirmed in other cohorts and include a longer follow-up phase. 
  
In conclusion, children with protracted bronchitis had the most severe ARI symptoms 
and higher percentage of respiratory morbidity at day 14.  In comparison to controls, 
children with asthma had more severe ARI symptoms only in the early phase (at and 
before 7 days).  As protracted bronchitis is an important and common cause of chronic 
cough in children (21) and possibly antecedent to chronic lung disease, further research 
studies  to ascertain the natural history and mechanisms underlying protracted 
bronchitis(29, 30) are important.   
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Table One: CARIFS(17) as completed by parents of children with asthma, protracted 
bronchitis and healthy controls.  
 Major 
Problem 
Moderate 
Problem 
Minor 
problem 
No 
Problem 
Don’t know/ 
Not applicable 
Fever      
Cough      
Poor appetite      
Not sleeping well      
Irritable      
Feels unwell      
Low energy, tired      
Not playing well      
Crying more than usual      
Needing extra care      
Clinginess      
Nasal congestion, runny 
nose 
     
Vomiting      
Not interested in what’s 
going on 
     
Unable to get out of bed      
Headache      
Sore throat      
Muscle aches and pains      
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Table Two: Demographics of study participants divided into children with asthma, 
protracted bronchitis and healthy controls. 
 
 Asthma group 
N=72 
Protracted bronchitis 
N=19 
Controls 
N=23 
 
Median age (IQR) 
 
Sex  
     Male (%) 
     Female 
 
Season 
     Winter (%) 
     Summer 
 
3.8 (3.8) 
 
 
39 (54.2) 
33 (45.8) 
 
 
43 (59.7) 
29 (40.3) 
 
3.3 (3.9) 
 
 
12 (63.2) 
7 (36.8) 
 
 
11 (57.9) 
8 (42.1) 
 
3.9 (3.4) 
 
 
14 (60.9) 
9 (39.1) 
 
 
10 (43.5) 
13 (56.5) 
 
 
 
 
 
 
 20 
 
 
Table Three: Median cough score and interquartile range (IQR) of 3 groups on days 1, 
7, 10 and 14. 
 
 
 
Children 
with 
Day 1 
 
Day 7 Day 10 Day 14 
Median IQR Median IQR Median IQR Median IQR 
Asthma 3.0 1.45 1.0 1.0 0 1.0 0 1.0 
Protacted 
bronchitis 
3.0 2.0 2.5 1.25 2.0 2.0 2.0 2.0 
Controls 1.0 1.0 1.0 2.75 1.0 2.0 1.0 1.25 
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Table Four: Proportion of children with asthma (A), protracted bronchitis (PB) and 
healthy controls (C) coughing at day 1, 7, 10, 14 of acute respiratory illness as per 
cough diary (19) 
   
 
 
Children with 
Day 1 
 
Day 7 Day 10 Day 14 
n % n % n % n % 
Asthma 49 68 31 43 20 28 14 24 
Protacted 
bronchitis 
12 63 13 68 14 74 12 63 
Controls 8 35 7 30 6 26 6 26 
p value <0.001 <0.001 <0.001 <0.001 
p by Kruskal Wallis comparing the 3 different groups on a particular day of ARI 
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 Figure Legend 
 
 
Figure One: Daily median CARIFS as reported by the parents of children with asthma 
(diamonds), protracted bronchitis (squares) and healthy controls (triangles) on day-1 of 
acute respiratory illness (ARI), day-7 of ARI, day-10 of ARI and day-14 of ARI. 
 
Figure Two: Median cough scores of children with asthma (diamonds), protracted 
bronchitis (squares) and healthy controls (triangles) against the day of acute respiratory 
illness (day 1, 7, 10 and 14) 
 
 
 
